Comments
Unichem Laboratories has entered into an agreement to acquire 20 per cent stake in the Active Pharmaceutical Ingredient (API) and intermediate business of Hyderabad-based Optimus group. The financial terms of the deal were not disclosed.
The transaction will give Unichem access to Optimus’ US Food and Drug Administration approved API manufacturing facilities, while Optimus will benefit from the knowledge base and industry best practices of Unichem, Unichem Laboratories said in a statement.
Trans-Continental Capital Advisors and Genesis Management Consultancy Services were the financial advisers to the transaction.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.